跳至主要内容
临床试验/NCT05246540
NCT05246540已完成不适用

Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2020年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Sensitivity / specificity of cervical PET/CT for the diagnosis of GCA

研究概览

简要总结

Giant cell arteritis (GCA) is the most common vasculitis in adults. The diagnosis of GCA is evoked by the association of clinical signs and biological anomalies (inflammatory syndrome) in patients over 50 years of age. On the other hand, starting a treatment implies being certain of the diagnosis which requires performing a temporal artery biopsy under local anesthesia. This examination is therefore an invasive procedure for patients whose sensitivity is not optimal. This is why imaging techniques (echo-Doppler or MRI of the temporal arteries) have been developed to look for signs of vasculitis without the need to perform a biopsy. However, these examinations lack sensitivity (=falsely concluding the absence of GCA) and specificity (=falsely concluding the presence of GCA). Recently, advances in imaging, and in particular positron emission tomography (PET), have made it possible to visualize the cephalic arteries, including the temporal artery.

The aim of this study is therefore to evaluate the sensitivity and specificity of PET of the cephalic arteries for the diagnosis of GCA and to compare them with those of echo-Doppler and MRI of the temporal arteries.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any patient for which the diagnosis of GCA is suspected and who underwent a cervical PET/CT

排除标准

  • previously diagnosed GCA, glycemia > 7 mmol/L, PET CT performed more than 72 h after introduction of glucocorticoids, age < 50 years

研究组 & 干预措施

Patients

干预措施: Data collection (Other)

结局指标

主要结局

Sensitivity / specificity of cervical PET/CT for the diagnosis of GCA

时间窗: 6 months

diagnosis retained by the clinician without question after 6 months of follow-up and treatment for at least 6 consecutive months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验